ユタにおける卵巣がんの臨床試験
ユタ内の拠点で、卵巣がんに関する29件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Intermountain Health, Salt Lake City
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- Start Mountain Region /ID# 278609, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07278336A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- START Center for Cancer Research, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Utah Cancer Specialists, Salt Lake City
被験者募集中第2相
18歳〜99歳 · 女性 · 2026/09/15更新 · NCT07023627FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- START Mountain Region, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06303505ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Utah Cancer Specialists, Salt Lake City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06774963Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07001748A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- START Mountain, Salt Lake City
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07470853Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/13更新 · NCT05985655A Study of MGC026 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- South Jordan Health Center, South Jordan
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- START Mountain Region, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Utah Cancer Specialists, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Utah Cancer Specialists Network, Salt Lake City
被験者募集中第3相
18歳以上 · 女性 · 2026/07/02更新 · NCT06819007A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT05377996Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- START Mountain Region, West Valley City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/10更新 · NCT07517198Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
- Huntsman Cancer Institute, Salt Lake City
被験者募集中観察研究健康なボランティア歓迎
21歳以上 · 女性 · 2026/04/09更新 · NCT06665945A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- START Center for Cancer Care - Mountain Region, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- LDS Hospital, Salt Lake City
被験者募集中第1相
18歳以上 · 女性 · 2026/02/03更新 · NCT06469281SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。